US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

58.76

+1.392.43%

Post-market: 58.800.0430+0.07%19:30 EDT

Volume:17.38K

Turnover:1.02M

Market Cap:284.38M

PE:19.22

High:59.14

Open:57.66

Low:57.66

Close:57.37

52wk High:64.10

52wk Low:44.47

Shares:4.84M

Float Shares:4.84M

Volume Ratio:0.51

T/O Rate:0.36%

Dividend:1.53

Dividend Rate:2.60%

EPS(TTM):3.06

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Arbutus Biopharma Repurchases 46,000,000 Shares for USD 230 Million in Modified Dutch Auction Tender Offer

New Grades, Price Targets for the Top-3 Stocks in the Market’s Hottest Sector

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), ClearPoint Neuro (CLPT) and Axsome Therapeutics (AXSM)

Axsome Therapeutics, Inc. : Deutsche Bank Cuts Target Price to $267 from $280

THOMSON REUTERS

Shenzhen Lifotronic Technology Secures Medical Device Registration Certificate for Photon Therapeutic Apparatus

Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Sells USD 743,436 in Common Shares

Revolution Medicines Seen Having 'Strong' Rasonque Launch in Pancreatic Cancer, UBS Says

MT Newswires Live

Healthcare Shows Resilience! Pharma ETF Huabao (562050) Rises Against the Market, Livzon Pharmaceutical Group Hits Limit Up! Medical Devices Show Localized Strength, Mindray and United Imaging Advance Together

Analysts Have Conflicting Sentiments on These Healthcare Companies: Roivant Sciences (ROIV) and Johnson & Johnson (JNJ)

Guardant Health (GH) Receives a Buy from Bernstein

Axsome's Auvelity Continues Positive Launch Trend, Mizuho Says

MT Newswires Live

UL Solutions warns of unauthorizd UL marks on carbon monoxide detectors

Revolution Medicines Director Elizabeth M. Anderson Disposes of $1,949,321.86 in Common Shares

FDA Advisors Said it Should Approve the Grail Multicancer Blood Test. the Stock Rises Sharply.

Huihe Medical's STAR Market IPO Application Terminated; Company Focuses on Innovative Medical Devices in Panvascular Intervention

Lifetech Scientific's SureCham Aortic Arch Single-Branch Stent Graft System Enters Special Review Pathway for Innovative Medical Devices

Bioperfectus Secures Two Medical Device Registration Certificates

Maccura Biotechnology Secures Three Medical Device Registration Certificates

Revolution Medicines (RVMD) Gets a Buy from Goldman Sachs

Wainwright maintains confidence in Immunovant’s pipeline despite CLE setback

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/PTH/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":58.757,"timestamp":1791576000000,"preClose":57.3658,"halted":0,"volume":17383,"hourTrading":{"tag":"盘后","latestPrice":58.8,"preClose":58.757,"latestTime":"19:30 EDT","volume":6,"amount":352.2346,"timestamp":1791588604239,"change":0.043,"changeRate":0.000732,"amplitude":0},"delay":0,"changeRate":0.024251383228334613,"floatShares":4840000,"shares":4840000,"eps":3.057033,"marketStatus":"Market Closed","change":1.3912,"latestTime":"10-09 16:00:00 EDT","open":57.66,"high":59.1447,"low":57.66,"amount":1021175.720865,"amplitude":0.025881,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":57.3658,"sharesOutstanding":2480000,"nav":57.33757,"aum":287288216.63,"dividendRate":0.02597,"bidAskSpread":0.001697,"preHourTrading":{"tag":"盘前","latestPrice":57.37,"preClose":57.3658,"latestTime":"07:00 EDT","volume":1,"amount":57.37,"timestamp":1791543606921,"change":0.0042,"changeRate":0.000073,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":58.8,"preClose":58.757,"latestTime":"19:30 EDT","volume":6,"amount":352.2346,"timestamp":1791588604239,"change":0.043,"changeRate":0.000732,"amplitude":0},"volumeRatio":0.5106189207267566,"impliedVol":0.2074,"impliedVolPercentile":0.9442},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4840000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5106189207267566,"shares":4840000,"dividePrice":1.5259,"high":59.1447,"amplitude":0.025881,"preClose":57.3658,"low":57.66,"week52Low":44.47,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":58.757,"eps":3.057033,"divideRate":0.02597,"volume":17383,"delay":0,"ttmEps":3.057033,"open":57.66,"prevYearClose":49.701,"prevWeekClose":60.2082,"prevMonthClose":60.76,"prevQuarterClose":60.76,"fiveDayClose":60.2082,"twentyDayClose":60.7692,"sixtyDayClose":58.2191},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671093162","title":"Arbutus Biopharma Repurchases 46,000,000 Shares for USD 230 Million in Modified Dutch Auction Tender Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2671093162","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671093162?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:30","pubTimestamp":1790767828,"startTime":"0","endTime":"0","summary":"Arbutus Biopharma repurchases 46,000,000 shares for USD 230 million in modified Dutch auction tender offerArbutus Biopharma expects to repurchase 46,000,000 common shares for cancellation in a modifie","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL8GWhnb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","ABUS","ROIV","BK4139","SG9999014039.USD","LU2210149790.SGD","IE00BQXX3D17.EUR","PTH","IE00BN0W2V16.EUR","IE00BQXX3F31.USD","BK4112","IE00B3QW5Z07.USD","BCDF","BK4007","IE00B64PRP62.GBP","SG9999014021.USD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","NDAQ","IE00BN0W2T93.GBP","BK4588","BK4585","LU0314104364.USD","SG9999014013.SGD","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014005.SGD","IE00BQXX3C00.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671117244","title":"New Grades, Price Targets for the Top-3 Stocks in the Market’s Hottest Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2671117244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671117244?lang=en_us&edition=fundamental","pubTime":"2026-09-30 02:43","pubTimestamp":1790707417,"startTime":"0","endTime":"0","summary":"How hot are biotech stocks? One of the bellwethers for the industry, the iShares Biotechnology ETF ($IBB) (left chart), has gained over 24% year to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/new-grades-price-targets-for-the-top-3-stocks-in-the-markets-hottest-sector?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/new-grades-price-targets-for-the-top-3-stocks-in-the-markets-hottest-sector?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","BK4585","XBIX","IBB","BK4550","BK4588","BIS","XLK","BIOY","FBT","JHMH","FXH","FDN","PTH","RXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671210199","title":"Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), ClearPoint Neuro (CLPT) and Axsome Therapeutics (AXSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671210199","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671210199?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:40","pubTimestamp":1790689233,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Novo Nordisk (NVO), ClearPoint Neuro (CLPT) and Ax...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novo-nordisk-nvo-clearpoint-neuro-clpt-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novo-nordisk-nvo-clearpoint-neuro-clpt-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLPT","AXSM","NVOH","BK4082","LU1093756325.SGD","OZEM","BK4532","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4585","BK4588","PPH","NVO","LU1093756168.USD","NVOX","BK4007","THNR","BK4599","LU2324357040.USD","PTH","BK4505","LU0154236417.USD","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671921642","title":"Axsome Therapeutics, Inc. : Deutsche Bank Cuts Target Price to $267 from $280","url":"https://stock-news.laohu8.com/highlight/detail?id=2671921642","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671921642?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:20","pubTimestamp":1790680843,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L0RM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","PTH","AXSM","LU2324357040.USD","BK4007","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101970069","title":"Shenzhen Lifotronic Technology Secures Medical Device Registration Certificate for Photon Therapeutic Apparatus","url":"https://stock-news.laohu8.com/highlight/detail?id=1101970069","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101970069?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:29","pubTimestamp":1790674165,"startTime":"0","endTime":"0","summary":"Shenzhen Lifotronic Technology Co.,Ltd. (688389.SH) has announced that its controlling subsidiary, Chongqing Lifotronic Biotechnology Co., Ltd., recently received the Medical Device Registration...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996","BK1583","GDOC","BK0251","HART","AGNG","PTH","LNGR","688389","LGHT","MDEV","RSPH","BK1100","159883","BK1574","IEIH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671013268","title":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Sells USD 743,436 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2671013268","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671013268?lang=en_us&edition=fundamental","pubTime":"2026-09-29 06:00","pubTimestamp":1790632843,"startTime":"0","endTime":"0","summary":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini sells USD 743,436 in common sharesRevolution Medicines Chief Global Commercialization Officer Anthony Mancini reported sales","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDLcdFr5m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Sells USD 743,436 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4139","RVMD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","IE0002141913.USD","CANC","IE00BJT1NW94.SGD","LU0320765992.SGD","BBH","LU0889565916.HKD","PTH","IE0009354923.USD","IDNA","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670259517","title":"Revolution Medicines Seen Having 'Strong' Rasonque Launch in Pancreatic Cancer, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2670259517","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670259517?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:58","pubTimestamp":1790611096,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) is expected to have a \"strong\" launch for its Rasonque drug in second-line pancreatic ductal adenocarcinoma patients, and in some first-line patients as well, UBS Securitie","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0109394709.USD","IE0002141913.USD","IE0009355771.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BBH","IE00B2B36J28.USD","LU0320765992.SGD","LU0889565916.HKD","PTH","BK4139","IE00BJJMRZ35.SGD","IDNA","IE00BJT1NW94.SGD","RVMD","CANC","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132272624","title":"Healthcare Shows Resilience! Pharma ETF Huabao (562050) Rises Against the Market, Livzon Pharmaceutical Group Hits Limit Up! Medical Devices Show Localized Strength, Mindray and United Imaging Advance Together","url":"https://stock-news.laohu8.com/highlight/detail?id=1132272624","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132272624?lang=en_us&edition=fundamental","pubTime":"2026-09-28 13:22","pubTimestamp":1790572929,"startTime":"0","endTime":"0","summary":"On the first trading day after the Mid-Autumn Festival (September 28), A-shares underwent a deep correction, with the Shanghai Composite Index falling nearly 2% at one point. Pharmaceutical assets...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IEIH","BK1161","HART","BK1574","BK0239","BK0187","BK0028","MEDX","PTH","MDEV","BK1583","LGHT","09996","BK1515","BK0188","GDOC","LNGR","09939","AGNG","159883","RSPH","159938","562050","BK1100","000513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670889472","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Roivant Sciences (ROIV) and Johnson & Johnson (JNJ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670889472","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670889472?lang=en_us&edition=fundamental","pubTime":"2026-09-27 01:00","pubTimestamp":1790442018,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roivant Sciences (ROIV) and Johnson & Johnson (JNJ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-roivant-sciences-roiv-and-johnson-johnson-jnj-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-roivant-sciences-roiv-and-johnson-johnson-jnj-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","FHLC","LABU","BMED","LU0234570918.USD","LU0124676726.USD","XLV","XBI","MEDX","LU0053666078.USD","BK4532","LU1674673428.USD","LU0069063385.USD","LU2403377893.USD","IYH","VHT","JDOC","RXL","LU1629891620.HKD","LU0234572021.USD","LU0738911758.USD","LU1280957306.USD","TRUH","BK4585","LU1061106388.HKD","LU0545562505.USD","LU2750360997.AUD","LU1929549753.HKD","LU2756315664.SGD","PTH","BK4007","JNJ","IXJ","LU0289739343.SGD","LU0058720904.USD","IE00BSNM7G36.USD","LU1430594728.SGD","BK4588","IHE","LU2430703095.HKD","LU0943347566.SGD","BK4550","GDOC","BK4581","FTXH","ROIV","LU0426417589.USD","LU0912757837.SGD","PJP","IE00BDGV0183.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670745514","title":"Guardant Health (GH) Receives a Buy from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2670745514","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670745514?lang=en_us&edition=fundamental","pubTime":"2026-09-26 22:15","pubTimestamp":1790432125,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Eve Burstein from Bernstein maintained a Buy rating on Guardant Health, with a price target of $210.00. The company...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guardant-health-gh-receives-a-buy-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guardant-health-gh-receives-a-buy-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNOM","FFOX","LU0889565916.HKD","LU0320765992.SGD","GNMX","PTH","GH","BK4196","EKG","BK4551","BK4535","LU0109394709.USD","GDOC","BK4588","HELX","BK4585","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670607429","title":"Axsome's Auvelity Continues Positive Launch Trend, Mizuho Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2670607429","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670607429?lang=en_us&edition=fundamental","pubTime":"2026-09-26 01:42","pubTimestamp":1790358164,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics  may benefit from continued momentum for its depression and Alzheimer's agitation treatment Auvelity, with prescription data showing solid weekly growth, Mizuho said Friday in a report.Data from Bloomberg Symphony and IQVIA indicated double-digit percentage increases in total and new prescriptions, suggesting Auvelity's launch in Alzheimer's agitation is off to an encouraging start, the report said.The positive trends emerge as competitor Acadia Pharmaceuticals  reported weaker phase 2 results in Alzheimer's-related psychosis, which may help Axsome's positioning in the Alzheimer's and depression treatment markets, Mizuho said.Mizuho maintained its outperform rating on Axsome with a $316 price target.Price: 196.49, Change: +0.46, Percent Change: +0.23","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2065170008.USD","BK4585","ACAD","LU2065171311.SGD","AXSM","LU2065171402.SGD","LU2324357040.USD","PTH","BK4505","LU2065169927.USD","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670544053","title":"UL Solutions warns of unauthorizd UL marks on carbon monoxide detectors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670544053","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670544053?lang=en_us&edition=fundamental","pubTime":"2026-09-25 20:36","pubTimestamp":1790339810,"startTime":"0","endTime":"0","summary":"UL Solutions (ULS) issued a public notice regarding Protech International carbon monoxide detectors, product model PTH-24D, which bear unauthorized...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ul-solutions-warns-of-unauthorizd-ul-marks-on-carbon-monoxide-detectors-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ul-solutions-warns-of-unauthorizd-ul-marks-on-carbon-monoxide-detectors-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ULS","BK4023","TUYA","PTH","BK4509","LU0106261612.USD","BK4123","LU0353189763.USD","LU0012050646.USD","LU2087625088.SGD","LU0353189680.USD","BK4505","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670415347","title":"Revolution Medicines Director Elizabeth M. Anderson Disposes of $1,949,321.86 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2670415347","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670415347?lang=en_us&edition=fundamental","pubTime":"2026-09-25 06:00","pubTimestamp":1790287241,"startTime":"0","endTime":"0","summary":"Revolution Medicines director Elizabeth M. Anderson disposes of $1,949,321.86 in common sharesElizabeth M. Anderson, director, cut her direct stake in Revolution Medicines common stock to 4,333 shares","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL3Nb1nM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Revolution Medicines Director Elizabeth M. Anderson Disposes of $1,949,321.86 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B2B36J28.USD","IE0002141913.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0320765992.SGD","PTH","RVMD","IE00BJJMRZ35.SGD","IDNA","IE00BJT1NW94.SGD","CANC","BBH","LU0109394709.USD","IE0009354923.USD","LU0889565916.HKD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669499070","title":"FDA Advisors Said it Should Approve the Grail Multicancer Blood Test. the Stock Rises Sharply.","url":"https://stock-news.laohu8.com/highlight/detail?id=2669499070","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669499070?lang=en_us&edition=fundamental","pubTime":"2026-09-24 22:52","pubTimestamp":1790261520,"startTime":"0","endTime":"0","summary":"Mizuho's Bradley Bowers thinks the boost will be substantial. He wrote Tuesday that sales doubled in the launch years of other cancer-screening products-like colon cancer stool test Cologuard from the Exact Sciences unit of Abbott, or the colon cancer blood test Shield from Guardant Health.Galleri screens a person's blood sample for bits of DNA showing features typical of cancer cells. It tells you if it has found a general signal of cancer somewhere in your body-\"Cancer Signal Detected\"-and makes its best guess at the kind of tissue where the cancer is hiding.Clinical trials showed Galleri can detect cancers for which there is no standard screen, such as cancer of the ovary or pancreas. Grail's two big clinical trials showed that it rarely tells you that you have cancer when you don't. When you do have cancer, the test finds it on average about 50% of the 60% of the time.That is good performance, compared with other widely used screens, like the mammogram. Grail plans to tell customer","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","SG9999002232.USD","FFOX","TMED","LU0868494617.USD","SG9999002224.SGD","LU1989763690.USD","EKG","SG9999004303.SGD","BK4196","SGXZ41872573.SGD","LU0122379950.USD","LU0889565916.HKD","BK4082","HELX","GNOM","LU2112291526.USD","LU2324357040.USD","BK4588","IE0002141913.USD","LU1670627923.USD","PJP","PTH","IHI","BK4585","GH","BK4139","LU0289739699.SGD","BK4551","GRAL","LABU","LU0211331839.USD","ABT","IE00B4R5TH58.HKD","LU2237957811.SGD","BK4568","LFSC","LU0320765489.SGD","LU1691799644.USD","BK4581","LU1721429402.USD","LU2468319806.SGD","LU0882574055.USD","GNMX","LU0320765992.SGD","SGXZ23171101.USD","LU2089984988.USD","BK4535","LU1721429741.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193610255","title":"Huihe Medical's STAR Market IPO Application Terminated; Company Focuses on Innovative Medical Devices in Panvascular Intervention","url":"https://stock-news.laohu8.com/highlight/detail?id=1193610255","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193610255?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:54","pubTimestamp":1790254489,"startTime":"0","endTime":"0","summary":"Huihe Medical's STAR Market IPO review status was changed to \"terminated\" on September 24, as the company and its sponsor withdrew the listing application, according to the relevant provisions of the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGHT","RSPH","IEIH","MDEV","MEDX","REDS","GDOC","BK1583","IPOS","FRHC","LNGR","159883","09996","KSTR","BK4127","PTH","BK1574","159891","HART","BK1100","KCE","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104658454","title":"Lifetech Scientific's SureCham Aortic Arch Single-Branch Stent Graft System Enters Special Review Pathway for Innovative Medical Devices","url":"https://stock-news.laohu8.com/highlight/detail?id=1104658454","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104658454?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:16","pubTimestamp":1790252179,"startTime":"0","endTime":"0","summary":"Lifetech Scientific (01302) has announced that on September 24, 2026, the company received formal written notification from the National Medical Products Administration confirming that the SureCham...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH","159883","AGNG","HART","01302","BK1600","BK1583","PTH","MEDX","GDOC","BK1100","IEIH","LGHT","BK1574","MDEV","09996","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131609096","title":"Bioperfectus Secures Two Medical Device Registration Certificates","url":"https://stock-news.laohu8.com/highlight/detail?id=1131609096","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131609096?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:20","pubTimestamp":1790241617,"startTime":"0","endTime":"0","summary":"Bioperfectus Technologies (688399.SH) announced that it has recently received medical device registration certificates (in vitro diagnostic reagents) issued by the National Medical Products...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688399","RSPH","LGHT","MEDX","LNGR","GDOC","HART","09996","BK1100","159883","BK1583","IEIH","BK1574","PTH","MDEV","BK0239","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198667592","title":"Maccura Biotechnology Secures Three Medical Device Registration Certificates","url":"https://stock-news.laohu8.com/highlight/detail?id=1198667592","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198667592?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:59","pubTimestamp":1790240378,"startTime":"0","endTime":"0","summary":"Maccura Biotechnology Co.,Ltd. (300463.SZ) has announced that the company recently received three Medical Device Registration Certificates issued by the Sichuan Provincial Medical Products...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK0046","LNGR","BK1583","MEDX","AGNG","BK1574","RSPH","159883","GDOC","IEIH","LGHT","HART","300463","BK0028","BK0239","MDEV","BK0012","09996","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669918463","title":"Revolution Medicines (RVMD) Gets a Buy from Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2669918463","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669918463?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:35","pubTimestamp":1790238933,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Andrea Newkirk resumed coverage with a Buy rating on Revolution Medicines today and set a price target of $267.00. Newkirk co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/revolution-medicines-rvmd-gets-a-buy-from-goldman-sachs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/revolution-medicines-rvmd-gets-a-buy-from-goldman-sachs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4552","LU2237443622.USD","IE00BJJMRZ35.SGD","LU0096364046.USD","LU0942090050.USD","IE00BJT1NW94.SGD","LU0345770308.USD","LU0210536198.USD","LU1144417596.USD","LU0109394709.USD","LU0345770993.USD","LU1791807156.HKD","LU2237443382.USD","GSX","LU0868494708.USD","BBH","BK4127","IE00BFTCPJ56.SGD","BK4550","LU0742534661.SGD","IE0002270589.USD","LU0251131958.USD","IE00B2B36J28.USD","LU0251142724.SGD","BK4588","LU2237443895.HKD","IE00B19Z3B42.SGD","LU1868836591.USD","PTH","LU2750360997.AUD","IE0034235188.USD","IE0004086264.USD","RVMD","IE00BFXG1179.USD","LU2471134523.USD","LU1668664300.SGD","IE00BSNM7G36.USD","LU1894683264.USD","LU0106831901.USD","LU1804176565.USD","BK4533","LU1894683348.USD","IE0009354923.USD","LU2896262040.SGD","LU2237438978.USD","LU0061475181.USD","LU2237443978.SGD","LU1868836757.USD","CANC","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669438437","title":"Wainwright maintains confidence in Immunovant’s pipeline despite CLE setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2669438437","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669438437?lang=en_us&edition=fundamental","pubTime":"2026-09-24 01:20","pubTimestamp":1790184011,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Douglas Tsao notes that this morning, Roivant Sciences (ROIV) reported that IMVT-1402 missed the Week 12 Cutaneous Lupus Er...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/wainwright-maintains-confidence-in-immunovants-pipeline-despite-cle-setback-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/wainwright-maintains-confidence-in-immunovants-pipeline-despite-cle-setback-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ROIV","PTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}